Intra-Cellular Therapies, Inc. Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc.

ITCI

Classificação em ações #1691
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on... Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on creating innovative treatments for conditions affecting the brain and nervous system. The company achieves this by targeting the intricate cellular communication pathways within the central nervous system, primarily operating in the United States. Its commercialized product is CAPLYTA, an approved therapy for schizophrenia in adult patients. Furthermore, the company maintains a robust development pipeline, including lumateperone, which is undergoing late-stage (Phase III) clinical trials for bipolar depression and is also being investigated for autism spectrum disorder and various sleep disturbances associated with neuropsychiatric and neurological illnesses. Other key drug candidates in its pipeline include Lenrispodun (ITI-214), aimed at treating Parkinson's disease and heart failure; ITI-1284-ODT-SL, designed to address neuropsychiatric disorders and behavioral challenges in dementia; and ITI-333, intended for substance use disorders, pain management, and co-occurring psychiatric conditions like depression and anxiety. Established in 2002, Intra-Cellular Therapies, Inc. has its headquarters situated in New York, New York.
Preço da ação
$131.87
Última sincronização: 2025-04-02
Valor de mercado
$12.68B
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Intra-Cellular Therapies, Inc. (ITCI)

Categoria

Healthcare
Histórico de desdobramentos de ações de Intra-Cellular Therapies, Inc. (ITCI)
As ações Intra-Cellular Therapies, Inc. (símbolo: ITCI) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Oct 20, 2026.
Uma ação ITCI comprada antes de Oct 20, 2026 equivaleria hoje a 0 ações ITCI.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes